In the tumour microenvironment, carboplatin induces the expression of VEGF, potentiating the anti-angiogenic effects of paclitaxel and bevacizumab through inhibition of endothelial cell migration and proliferation [109]. This evidence concerns the gene VEGFA and neoplasm.